Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial Fibrillation
暂无分享,去创建一个
Michael J Pencina | Adrian F Hernandez | Haolin Xu | Li Liang | Eric E. Smith | Ying Xian | DaiWai M Olson | Emily C. O'Brien | Deepak L. Bhatt | Gregg C Fonarow | Deepak L Bhatt | M. Pencina | G. Fonarow | E. Peterson | L. Schwamm | L. Liang | Adrian F. Hernandez | E. O'Brien | Daiwai M. Olson | Y. Xian | Lesley Maisch | Haolin Xu | Eric D Peterson | Eric E Smith | Lee H Schwamm | Barbara L Lytle | B. Lytle | Emily C O'Brien | Lesley Maisch | Deidre Hannah | Brianna Lindholm | Deidre Hannah | Brianna Lindholm | E. Smith
[1] Eric E. Smith,et al. Representativeness of the Get With The Guidelines–Stroke Registry: Comparison of Patient and Hospital Characteristics Among Medicare Beneficiaries Hospitalized With Ischemic Stroke , 2012, Stroke.
[2] Lesley Maisch,et al. Certain uncertainty: life after stroke from the patient's perspective. , 2014, Circulation. Cardiovascular quality and outcomes.
[3] V. Chair,et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. , 2014, Stroke.
[4] G. Breithardt,et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. , 2011, The New England journal of medicine.
[5] D. Singer,et al. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. , 1996, The New England journal of medicine.
[6] A. Rabinstein. Characteristics, Performance Measures, and In-Hospital Outcomes of the First One Million Stroke and Transient Ischemic Attack Admissions in Get With The Guidelines-Stroke , 2010 .
[7] Gregory Y H Lip,et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. , 2010, Chest.
[8] G. Lip,et al. Underuse of oral anticoagulants in atrial fibrillation: a systematic review. , 2010, The American journal of medicine.
[9] Eric E. Smith,et al. Real world effectiveness of warfarin among ischemic stroke patients with atrial fibrillation: observational analysis from Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) study , 2015, BMJ : British Medical Journal.
[10] Yuchiao Chang,et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. , 2003, The New England journal of medicine.
[11] J. Marler,et al. Measurements of acute cerebral infarction: a clinical examination scale. , 1989, Stroke.
[12] Eric E. Smith,et al. Data quality in the American Heart Association Get With The Guidelines-Stroke (GWTG-Stroke): results from a national data validation audit. , 2012, American heart journal.
[13] Comparison of 12 Risk Stratification Schemes to Predict Stroke in Patients With Nonvalvular Atrial Fibrillation , 2008, Stroke.
[14] D. Atar,et al. Apixaban versus warfarin in patients with atrial fibrillation. , 2011, The New England journal of medicine.
[15] S M Nazarian,et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. , 1992, The New England journal of medicine.
[16] R. Becker,et al. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. , 2005, Journal of the American College of Cardiology.
[17] E. Antman,et al. Edoxaban versus warfarin in patients with atrial fibrillation. , 2013, The New England journal of medicine.
[18] L. Poller,et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. , 1993, The New England journal of medicine.
[19] Martha J. Radford,et al. Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation , 2001 .
[20] Li Liang,et al. Get With the Guidelines–Stroke Is Associated With Sustained Improvement in Care for Patients Hospitalized With Acute Stroke or Transient Ischemic Attack , 2009, Circulation.
[21] Eric E. Smith,et al. Clinical Effectiveness of Statin Therapy After Ischemic Stroke: Primary Results From the Statin Therapeutic Area of the Patient‐Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study , 2015, Circulation.
[22] H. Kluin-Nelemans,et al. Risk of Bleeding and Thrombosis in Patients 70 Years or Older Using Vitamin K Antagonists. , 2016, JAMA internal medicine.
[23] Emily C. O'Brien,et al. Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research: Implementing the patient-driven research paradigm to aid decision making in stroke care. , 2015, American heart journal.
[24] Leon Poller,et al. Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.
[25] M. Fornage,et al. Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.
[26] J. Slattery,et al. Interobserver agreement for the assessment of handicap in stroke patients. , 1989, Stroke.
[27] D. Singer,et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.
[28] Mark D. Huffman,et al. Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association , 2016, Circulation.
[29] A. Laupacis,et al. Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. , 1999, Archives of internal medicine.
[30] David J. Gladstone,et al. Potentially Preventable Strokes in High-Risk Patients With Atrial Fibrillation Who Are Not Adequately Anticoagulated , 2009, Stroke.
[31] M. Turakhia,et al. Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke. , 2016, Journal of the American College of Cardiology.
[32] A. Rabinstein. Get With the Guidelines–Stroke Is Associated With Sustained Improvement in Care for Patients Hospitalized With Acute Stroke or Transient Ischemic Attack , 2009 .
[33] G. Guyatt,et al. Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study , 2006, The Lancet Neurology.
[34] W R Clarke,et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke , 1999, Neurology.
[35] E. Hylek,et al. National Assessment of Warfarin Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation , 2014, Circulation.
[36] Theresa M Beckie,et al. American Heart Association Council on Cardiovascular and Stroke Nursing. , 2013, The Journal of cardiovascular nursing.
[37] S. Yusuf,et al. Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.
[38] R. Rosenfeld. Patients , 2012, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[39] Candice L. Garwood,et al. Use of Anticoagulation in Elderly Patients with Atrial Fibrillation Who Are at Risk for Falls , 2008, The Annals of pharmacotherapy.